ZAIDYN

Bayer signs multiyear agreement with ZS to extend use of ZAIDYN™ Customer Engagement

June 14, 2024 | Press Release | 2-minute read





Three-year agreement provides Bayer with continued access to AI-powered engagement platform for personalized sales impact

 

Evanston, Ill. – June 14, 2024 – ZS, a global management consulting and technology firm, announced today that Bayer has signed a three-year renewal agreement to use ZS’s ZAIDYN™ Customer Engagement platform for life sciences decision-making. Bayer has been an active user of the innovative platform since 2020, and the new agreement extends the partnership through 2026.

 

Through the ZAIDYN Customer Engagement platform, powered by AWS technologies, ZS and Bayer created and implemented a unique suggestion engine powered by AI and machine learning that’s tailored specifically for the pharmaceutical company. It generates automated, real-time responses to inquiries by Bayer’s field personnel so they can deliver bespoke, personalized experiences to healthcare providers, medical science liaisons and other key contacts. Bayer has used ZAIDYN Customer Engagement across 30 of its different brands in 19 markets across the globe.

 

“For nearly four years, ZAIDYN Customer Engagement has simplified how our reps deliver the right message to the right contact,” said Hari Krishna Iyer, Bayer’s head of suggestion engine and decision science operations. “ZS’s focus on AI technologies and its deep understanding of Bayer’s operations have helped us achieve increased commercial success since implementing ZAIDYN Customer Engagement.” 

 

Aditya Dhingra, a ZS principal focusing on digital, AI and technology, said ZS is using generative AI to continuously expand and further advance Bayer’s suggestion engine within ZAIDYN Customer Engagement. The two firms are actively collaborating to add gen-AI-powered features to the solution, including conversational AI capabilities.

 

“Our team is very pleased that the ZAIDYN Customer Engagement platform has played such a key role in Bayer’s efforts to drive personalized customer relationships. We’re excited to continue working with Bayer’s talented decision sciences group,” Dhingra said. “Our focus on advanced AI capabilities is already paying dividends for Bayer field reps who are building and maintaining the relationships essential to success.” 

About ZS



ZS is a management consulting and technology firm focused on transforming global healthcare and beyond. We leverage our leading-edge analytics, plus the power of data, science and tech products, to help our clients make more intelligent decisions, deliver innovative solutions and improve outcomes for all. Founded in 1983, ZS has more than 13,000 employees in 35 offices worldwide. To learn more, visit www.zs.com or follow us on LinkedIn.

Media contacts



For more information, please contact our media relations team.

Contact
 

Quintin Maidment

The Bliss Group

zs@theblissgrp.com

+1 212 600 2584